Does Chemoradiotherapy Boost Survival in Endometrial Cancer?
The addition of radiation to chemotherapy did not improve overall survival in patients with locally advanced endometrial cancer, a recent phase 3 trial found.
Related Articles
‘Groundbreaking’ potential cure for sickle cell in England approved for NHS use
Clinical trials find one-time gene therapy exa-cel offers ‘functional cure’ in 96.6% of patients
The interplay between acute and late toxicity among patients receiving prostate radiotherapy: an individual patient data meta-analysis of six randomised trials
Acute toxicity following prostate radiotherapy was statistically significantly associated with late toxicity and with decrement in patient-reported QOL metrics. These data support efforts to evaluate…
How the PGA and NBA Can Prepare You for Your Next Medical Appointment
No one has a greater stake in your healthcare than you do.
How to decode a toothpaste ingredients label
What the ingredients in a tube of toothpaste mean for your teeth and gums.
EXCLUSIVE: NSF starts vetting all grants to comply with Trump’s orders
Grantee accounts remain frozen, while union accuses NSF of ignoring rules governing peer review
CYP2D6 Genotyping and Inhibition as Predictors of Adverse Drug Reactions in Depressive Disorders – PubMed
Objective: The primary aim of this study was to examine the association between the different predicted phenotypes of the polymorphic CYP2D6 gene and the prevalence…
Evaluating the side effects of 2L treatment for upper gastrointestinal cancer
Timothy Brown, MD, UT Southwestern Medical Center, Dallas, TX, highlights the importance of dialogue between patients and clinicians regarding the side effects and treatment logistics…
Modelos de aula invertida ¿Qué es lo que puedes aplicar a tu realidad? – 2025
Descubre cómo implementar el método de aula invertida en tu clase y potencia la participación de tus estudiantes.
SABCS Snippets: FDA Approval of Dato-DXd
Hope S. Rugo, MD, of the University of California San Francisco, and Kate Lathrop, MD, SABCS Program Director, discuss the recent FDA approval of datopotamab…
Thoracic Radiotherapy Improves the Survival in Patients With EGFR-Mutated Oligo-Organ Metastatic Non–Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III Trial
PURPOSEThis multicenter, randomized, phase III clinical trial (Northern Radiation Oncology Group of China-002) focused on patients with oligo-organ metastatic non–small cell lung cancer (NSCLC) who…
